Virtual Clinical Trials Market Trends, Industry Overview, Latest Insights, Opportunity and Forecast 2022-2027

According to IMARC Group's latest report, titled "Virtual Clinical Trials Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", the global virtual clinical trials market is expected to exhibit a CAGR of 5.6% during 2022-2027.

Virtual clinical trials (VCT) refer to the clinical tests that are conducted remotely using advanced technological solutions. These virtual trials involve the use of smartphone applications and electronic monitoring devices to diagnose, detect and prevent diseases, along with several web-based platforms to recruit, counsel, measure endpoints and obtain data from the subjects. They also help in generating data regarding the efficiency, effectiveness, and safety of drugs and medical procedures. Compared to the traditional clinical trials, VCTs are less time-consuming, ensure real-time data acquisition and are not affected by delays in patient recruitment as they can be conducted at-home or at remote locations.

Request for a PDF sample of this report: https://www.imarcgroup.com/virtual-clinical-trials-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Virtual Clinical Trials Market Trends:

The rising digitization of the healthcare infrastructures is primarily driving the growth of the market. Besides this, as coronavirus disease continues to spread across the world, there has been a considerable increase in the demand for virtual and remote testing solutions for safe and effective data collection. Furthermore, numerous technological innovations, such as the introduction of virtual patient interaction platforms and the utilization of wearable devices, are acting as other growth-inducing factors. These technologies assist in connecting patients with treating physicians through telemedicine platforms and obtaining e-consent for the trials, thus strengthening the market growth. Additionally, the growing adoption of cloud-based, web-hosted and open-source licensing delivery models is anticipated to further propel the market in the coming years. Looking forward, IMARC Group expects the global virtual clinical trials market to exhibit moderate growth during 2021-2026.

Virtual Clinical Trials Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape with Key Players:

The competitive landscape of the global virtual clinical trials market has also been examined along with the profiles of the key players.

Some of these key players include:

Clinical Ink Inc.
Covance Inc.
ICON Plc, IQVIA Inc.
LEO Innovation Lab
Medable Inc.
Medidata Solutions Inc. (Dassault Systèmes SE)
Medpace Holdings Inc.
Oracle Corporation
Parexel International Corporation
PRA Health Sciences
Signant Health.

Key Market Segmentation:

The report has segmented the virtual clinical trials market based on study design, indication, and region.

Breakup by Study Design:

Interventional
Observational
Expanded Access

Breakup by Indication:

Oncology
Cardiovascular
Others

Breakup by Region:

North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=3221&flag=C

Key highlights of the report:

Market Performance (2015-2020)
Market Outlook (2021-2026)
Market Trends
Market Drivers and Success Factors
Impact of COVID-19
Value Chain Analysis
Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Related Reports by IMARC Group:

United States Minimally Invasive Surgery Market: https://bit.ly/3Eqs4Ym

GCC Minimally Invasive Surgery Market: https://bit.ly/3SItmCk

Regulatory Affairs Outsourcing Market: https://bit.ly/3ypi4e2

Multiple Sclerosis Therapies Market: https://bit.ly/3SZbRgC

Dental Implants Market: https://bit.ly/3EpBVgR

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.